ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,058Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 231

$881K Total Retail Price of All Prescriptions

Rank: 4 out of 231

384 Patients Receiving at Least One Drug in Part D
49%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 384 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

5% of this provider’s 384 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 3,548 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$109 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
LEVOTHYROXINE SODIUM 269 139 1 3
SIMVASTATIN 263 154 2 2
LISINOPRIL 215 135 3 1
AMLODIPINE BESYLATE 206 108 4 4
OMEPRAZOLE 204 79 5 5
ZOLPIDEM TARTRATE 185 80 6 14
FUROSEMIDE 178 93 7 6
METFORMIN HCL 158 109 8 7
GABAPENTIN 154 72 9 15
CRESTOR 144 46 10 19
PROAIR HFA 134 37 11 59
PRAVASTATIN SODIUM 132 76 12 10
ATORVASTATIN CALCIUM 123 79 13 8
ALENDRONATE SODIUM 111 63 14 45
HYDROCHLOROTHIAZIDE 102 69 15 9
METOPROLOL SUCCINATE 102 33 15 13
NEXIUM 98 35 17 31
SPIRIVA 89 18 18 61
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 52 19 22
PEN NEEDLE 83 28 20 116
CARVEDILOL 81 50 21 24
ADVAIR DISKUS 78 11 22 50
LANTUS SOLOSTAR 78 15 22 90
AMPHETAMINE SALT COMBO 70 0 S2 24 192
CITALOPRAM HBR 68 22 25 20
POLYETHYLENE GLYCOL 3350 66 0 26 36
SYMBICORT 64 21 27 170
NIASPAN 61 31 28 157
AZITHROMYCIN 61 21 28 32
CLOPIDOGREL 59 43 30 44
METOPROLOL TARTRATE 59 43 30 12
TAMSULOSIN HCL 58 33 32 30
DIOVAN 58 30 32 27
GLIMEPIRIDE 56 40 34 38
ESCITALOPRAM OXALATE 56 29 34 55
RANITIDINE HCL 55 12 36 51
CYMBALTA 55 12 36 46
ATENOLOL 53 42 38 11
AMOXICILLIN 53 21 38 113
NOVOLOG FLEXPEN 51 13 40 231
CYCLOBENZAPRINE HCL 50 0 R 41 86
TRAMADOL HCL 50 20 41 16
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.